<DOC>
	<DOCNO>NCT01695343</DOCNO>
	<brief_summary>The purpose study confirm extend Phase 1-2 KB001 finding airway anti-inflammatory effect CF individual chronic Pseudomonas aeruginosa ( Pa ) airway infection . It hypothesize steady-state level KB001-A CF subject airway Pa infection safe well-tolerated , increase time-to-need antibiotic treatment ( IV , inhale , oral ) worsen respiratory tract sign symptom compare placebo .</brief_summary>
	<brief_title>Study Evaluate Effect KB001-A Time-to-Need Antibiotic Treatment</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Individuals CF old 50 year age may participate treat 2 course antibiotic ( IV and/or oral ) respiratory sign symptom ( CF exacerbation ) 12 month Screening Visit Confirmed diagnosis CF At least 2 respiratory tract culture previous 12 month , Pa present . The recent positive Pa culture must within 12 week Screening Visit ( obtain positive culture screen ) FEV1 % level within acceptable range ( per study protocol ) Received inhaled ABX equivalent 8 week great 26 week Day 0 Visit Treatment antibiotic acute illness within 4 week Day 0 Visit Use systemic corticosteroid within 4 week Day 0 Visit Any change regimen CF maintenance therapy within 4 week Day 0 Visit History sputum culture positive B. cepacia complex 2 year Screening Visit History organ transplantation Current smoker ( tobacco , marijuana , material ) . Use smokeless inhalers/vaporizers material also prohibit History drug addiction alcohol abuse 12 month Screening Visit History hepatic disease ( clinical cirrhosis portal hypertension ) , renal dysfunction Breastfeeding pregnancy evidence positive blood pregnancy test Receiving investigational drug 16 week ( 5 half life ) Day 0 Visit , whichever long</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>Pseudomonas aeruginosa ( Pa )</keyword>
	<keyword>CF</keyword>
</DOC>